Diffuse goitre enlargement after immunotherapy for non‐small cell lung cancer. Issue 11 (12th October 2021)

• Record Type: Journal Article
• Authors: Fujita, Kohei; Araki, Norio; Mio, Tadashi
• Is Part Of: Respirology case reports. Volume 9:Issue 11(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-10-12
• Subjects: goitre enlargement -- immunotherapy -- nivolumab -- PD‐1 -- thyroid; Respiratory organs -- Diseases -- Periodicals; 616.2005
• DOI: 10.1002/rcr2.866
• Languages: English
• ISSNs: 2051-3380

Abstract

Key message: It is well known that a phenomenon called hyperprogressive disease (HPD) often occurs during immunotherapy with immune checkpoint inhibitors. In the present case, we experienced a case of HPD in a potential metastatic thyroid tumour during immunotherapy. HPD can be life‐threatening depending on where it appears, so clinicians need to be careful. Abstract : We experienced a case of hyperprogressive disease (HPD) in a potential metastatic thyroid tumour during immunotherapy. HPD can be life‐threatening depending on where it appears, so clinicians need to be careful.